Solid Biosciences Inc(NASDAQ:SLDB) 
Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expre...
Website: http://www.solidbio.com
Founded: 2013
Full Time Employees: 121
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.34
H 3.37
L 3.06
C 3.12
V 1,605,029
10EMA 3.12
20EMA 3.12
60EMA 3.12
120EMA 3.12
250EMA 3.12